发明名称 |
Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients |
摘要 |
Described herein are methods of treating a mammal in need of treatment for non-histaminic pruritus by administering to the mammal in need thereof a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof, thereby reducing the desire to scratch in the mammal. Non-histaminergic types of pruritus are resistant to treatment with selective histamine H-1-, H-2- and H-4-receptor inhibitors. In certain aspects, the non-histaminergic pruritus is associated with diabetes. |
申请公布号 |
US9439895(B2) |
申请公布日期 |
2016.09.13 |
申请号 |
US201615134807 |
申请日期 |
2016.04.21 |
申请人 |
BRIDGE PHARMA, INC. |
发明人 |
Aberg A.K. Gunnar;Ciofalo Vincent B. |
分类号 |
A01N43/40;A61K31/445;A61K31/4535;A61K9/00 |
主分类号 |
A01N43/40 |
代理机构 |
Cantor Colburn LLP |
代理人 |
Cantor Colburn LLP |
主权项 |
1. A method of treating a mammal in need of treatment for non-histaminic pruritus, comprising orally administering to the mammal in need thereof a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof, thereby reducing the desire to scratch in the mammal, wherein the non-histaminergic pruritus is resistant to treatment with selective histamine H-1-receptor inhibitors, histamine H-2-receptor inhibitors and histamine H-4-receptor inhibitors, and wherein the mammal is suffering from diabetes mellitus. |
地址 |
Sarasota FL US |